BPMC logo

Blueprint Medicines (BPMC) CAPEX

Annual CAPEX

$16.06 M
+$7.14 M+80.09%

December 31, 2023

Summary

Performance

1-Year Change

+80.09%

3-Year Change

+408.45%

5-Year Change

+26.7%

15-Year Change

+3.55%

BPMC CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

71.55%
BPMC annual capital expenditures is higher than 71.55% of companies in Healthcare sector

High & Low

All-time High

$261.24 M
BPMC annual capital expenditures is currently -93.85% below its historical high of $261.24 million

3-Year Low

$8.92 M
BPMC annual capital expenditures is currently +80.09% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
BPMC previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 14, 2025
BPMC next annual earnings announcement is scheduled for Feb 14, 2025

OtherBPMCcash flowmetrics:

Annual FCF

-$452.91 M
BPMC annual free cash flow is -$452.91 million

Annual CFO

-$436.85 M
BPMC annual cash flow from operations is -$436.85 million

Annual CFI

$274.04 M
BPMC annual cash flow from investing activities is $274.04 million

Annual CFF

$119.22 M
BPMC annual cash flow from financing activities is $119.22 million

Quarterly CAPEX

$25.00 K
-$2.54 M-99.03%

September 30, 2024

Summary

Performance

3-Month Change

-99.03%

1-Year Change

-99.6%

3-Year Change

-99.02%

5-Year Change

-99.02%

BPMC Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

18.68%
BPMC quarterly capital expenditures is higher than 18.68% of companies in Healthcare sector

High & Low

All-time High

$259.41 M
BPMC quarterly capital expenditures is currently -99.99% below its historical high of $259.41 million

3-Year Low

$25.00 K
BPMC quarterly capital expenditures is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
BPMC previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 14, 2025
BPMC next earnings announcement is scheduled for Feb 14, 2025

OtherBPMCcash flowmetrics:

Quarterly FCF

-$13.66 M
BPMC quarterly free cash flow is -$13.66 million

Quarterly CFO

-$13.64 M
BPMC quarterly cash flow from operations is -$13.64 million

Quarterly CFI

$29.95 M
BPMC quarterly cash flow from investing activities is $29.95 million

Quarterly CFF

$18.38 M
BPMC quarterly cash flow from financing activities is $18.38 million

TTM CAPEX

$8.37 M
-$6.23 M-42.65%

September 30, 2024

Summary

Performance

3-Month Change

-42.65%

1-Year Change

-34.96%

3-Year Change

-19.11%

5-Year Change

-19.11%

BPMC TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

61.62%
BPMC TTM capital expenditures is higher than 61.62% of companies in Healthcare sector

High & Low

All-time High

$266.85 M
BPMC TTM capital expenditures is currently -96.86% below its historical high of $266.85 million

3-Year Low

$8.37 M
BPMC TTM capital expenditures is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
BPMC previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 14, 2025
BPMC next earnings announcement is scheduled for Feb 14, 2025

OtherBPMCcash flowmetrics:

TTM FCF

-$250.52 M
BPMC TTM free cash flow is -$250.52 million

TTM CFO

-$242.15 M
BPMC TTM cash flow from operations is -$242.15 million

TTM CFI

-$2.44 M
BPMC TTM cash flow from investing activities is -$2.44 million

TTM CFF

$278.88 M
BPMC TTM cash flow from financing activities is $278.88 million

BPMC CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+80.1%-99.6%-35.0%
3 y3 years+408.4%-99.0%-19.1%
5 y5 years+26.7%-99.0%-19.1%

BPMC CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-93.8%+80.1%-100.0%at low-96.9%at low
5 y5-year-93.8%+408.4%-100.0%+316.7%-96.9%+447.8%
alltimeall time-93.8%+582.3%-100.0%+316.7%-96.9%>+9999.0%

Blueprint Medicines CAPEX History

DateAnnualQuarterlyTTM
Sep 2024
-
$25.00 K(-99.0%)
$8.37 M(-42.7%)
Jun 2024
-
$2.57 M(+132.7%)
$14.60 M(+0.1%)
Mar 2024
-
$1.10 M(-76.4%)
$14.58 M(-9.2%)
Dec 2023
$16.06 M(+80.1%)
$4.67 M(-25.2%)
$16.06 M(+24.8%)
Sep 2023
-
$6.25 M(+144.8%)
$12.87 M(+24.4%)
Jun 2023
-
$2.55 M(-1.2%)
$10.35 M(-0.0%)
Mar 2023
-
$2.58 M(+74.5%)
$10.35 M(+16.0%)
Dec 2022
$8.92 M(-96.6%)
$1.48 M(-60.3%)
$8.92 M(-96.7%)
Sep 2022
-
$3.73 M(+45.9%)
$266.85 M(+1.0%)
Jun 2022
-
$2.56 M(+121.7%)
$264.12 M(+0.7%)
Mar 2022
-
$1.15 M(-99.6%)
$262.22 M(+0.4%)
Dec 2021
$261.24 M(+8169.7%)
$259.41 M(>+9900.0%)
$261.24 M(>+9900.0%)
Sep 2021
-
$996.00 K(+50.5%)
$2.52 M(+64.8%)
Jun 2021
-
$662.00 K(+282.7%)
$1.53 M(-15.4%)
Mar 2021
-
$173.00 K(-74.8%)
$1.81 M(-42.8%)
Dec 2020
$3.16 M(-77.5%)
$687.00 K(>+9900.0%)
$3.16 M(-50.4%)
Sep 2020
-
$6000.00(-99.4%)
$6.36 M(-49.3%)
Jun 2020
-
$941.00 K(-38.3%)
$12.54 M(-8.9%)
Mar 2020
-
$1.52 M(-60.8%)
$13.77 M(-1.7%)
DateAnnualQuarterlyTTM
Dec 2019
$14.01 M(+10.5%)
$3.89 M(-37.1%)
$14.01 M(+32.9%)
Sep 2019
-
$6.18 M(+184.9%)
$10.55 M(+51.0%)
Jun 2019
-
$2.17 M(+22.6%)
$6.98 M(-14.2%)
Mar 2019
-
$1.77 M(+316.5%)
$8.13 M(-35.8%)
Dec 2018
$12.68 M(-18.3%)
$425.00 K(-83.8%)
$12.68 M(-44.5%)
Sep 2018
-
$2.62 M(-21.2%)
$22.83 M(-7.5%)
Jun 2018
-
$3.32 M(-47.4%)
$24.69 M(+14.2%)
Mar 2018
-
$6.31 M(-40.3%)
$21.61 M(+39.3%)
Dec 2017
$15.51 M(+559.0%)
$10.58 M(+136.4%)
$15.51 M(+213.4%)
Sep 2017
-
$4.47 M(+1711.7%)
$4.95 M(+396.5%)
Jun 2017
-
$247.00 K(+17.6%)
$997.00 K(-23.4%)
Mar 2017
-
$210.00 K(+1066.7%)
$1.30 M(-44.7%)
Dec 2016
$2.35 M(-51.8%)
$18.00 K(-96.6%)
$2.35 M(-61.3%)
Sep 2016
-
$522.00 K(-5.4%)
$6.09 M(-4.7%)
Jun 2016
-
$552.00 K(-56.3%)
$6.39 M(+4.3%)
Mar 2016
-
$1.26 M(-66.4%)
$6.13 M(+25.5%)
Dec 2015
$4.88 M
$3.75 M(+356.7%)
$4.88 M(+332.5%)
Sep 2015
-
$822.00 K(+185.4%)
$1.13 M(+267.8%)
Jun 2015
-
$288.00 K(+1415.8%)
$307.00 K(+1515.8%)
Mar 2015
-
$19.00 K
$19.00 K

FAQ

  • What is Blueprint Medicines annual capital expenditures?
  • What is the all time high annual CAPEX for Blueprint Medicines?
  • What is Blueprint Medicines annual CAPEX year-on-year change?
  • What is Blueprint Medicines quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Blueprint Medicines?
  • What is Blueprint Medicines quarterly CAPEX year-on-year change?
  • What is Blueprint Medicines TTM capital expenditures?
  • What is the all time high TTM CAPEX for Blueprint Medicines?
  • What is Blueprint Medicines TTM CAPEX year-on-year change?

What is Blueprint Medicines annual capital expenditures?

The current annual CAPEX of BPMC is $16.06 M

What is the all time high annual CAPEX for Blueprint Medicines?

Blueprint Medicines all-time high annual capital expenditures is $261.24 M

What is Blueprint Medicines annual CAPEX year-on-year change?

Over the past year, BPMC annual capital expenditures has changed by +$7.14 M (+80.09%)

What is Blueprint Medicines quarterly capital expenditures?

The current quarterly CAPEX of BPMC is $25.00 K

What is the all time high quarterly CAPEX for Blueprint Medicines?

Blueprint Medicines all-time high quarterly capital expenditures is $259.41 M

What is Blueprint Medicines quarterly CAPEX year-on-year change?

Over the past year, BPMC quarterly capital expenditures has changed by -$6.23 M (-99.60%)

What is Blueprint Medicines TTM capital expenditures?

The current TTM CAPEX of BPMC is $8.37 M

What is the all time high TTM CAPEX for Blueprint Medicines?

Blueprint Medicines all-time high TTM capital expenditures is $266.85 M

What is Blueprint Medicines TTM CAPEX year-on-year change?

Over the past year, BPMC TTM capital expenditures has changed by -$4.50 M (-34.96%)